Moreover, circulating complexes of VWF and CXCL4 have been identified in patients with thrombocytopenic purpura, suggesting that CXCL4 contributes to microvascular thrombosis by inhibiting ADMTS13 (70). This evidence concerns the gene PF4 and thrombocytopenic purpura.